Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Nancy Lynn Keating, M.D.

Co-Author

This page shows the publications co-authored by Nancy Keating and Haiden Huskamp.
Connection Strength

5.899
  1. Long and short hospice stays among nursing home residents at the end of life. J Palliat Med. 2010 Aug; 13(8):957-64.
    View in: PubMed
    Score: 0.455
  2. Variation in patients' hospice costs. Inquiry. 2008; 45(2):232-44.
    View in: PubMed
    Score: 0.381
  3. Coverage and prior authorization of psychotropic drugs under Medicare Part D. Psychiatr Serv. 2007 Mar; 58(3):308-10.
    View in: PubMed
    Score: 0.359
  4. The new medicare drug benefit: formularies and their potential effects on access to medications. J Gen Intern Med. 2005 Jul; 20(7):662-5.
    View in: PubMed
    Score: 0.320
  5. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D. JAMA Intern Med. 2021 Oct 18.
    View in: PubMed
    Score: 0.248
  6. Authorized Generics and Their Evolving Role in Prescription Drug Pricing and Access. JAMA Intern Med. 2021 Apr 01; 181(4):423-424.
    View in: PubMed
    Score: 0.238
  7. Broken Promises - How Medicare Part D Has Failed to Deliver Savings to Older Adults. N Engl J Med. 2020 Dec 10; 383(24):2299-2301.
    View in: PubMed
    Score: 0.233
  8. Oral Oncology Parity Laws, Medication Use, and Out-of-Pocket Spending for Patients With Blood Cancers. J Natl Cancer Inst. 2020 10 01; 112(10):1055-1062.
    View in: PubMed
    Score: 0.230
  9. Medicare Part D and Insulin Affordability - The Devil Is in the Details. N Engl J Med. 2020 May 14; 382(20):1878-1880.
    View in: PubMed
    Score: 0.223
  10. Proposals to Redesign Medicare Part D - Easing the Burden of Rising Drug Prices. N Engl J Med. 2019 Oct 10; 381(15):1401-1404.
    View in: PubMed
    Score: 0.214
  11. Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019. JAMA. 2019 05 28; 321(20):2025-2027.
    View in: PubMed
    Score: 0.210
  12. Factors Contributing To Geographic Variation In End-Of-Life Expenditures For Cancer Patients. Health Aff (Millwood). 2018 07; 37(7):1136-1143.
    View in: PubMed
    Score: 0.197
  13. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws. JAMA Oncol. 2018 06 14; 4(6):e173598.
    View in: PubMed
    Score: 0.196
  14. Diffusion of Bevacizumab Across Oncology Practices: An Observational Study. Med Care. 2018 01; 56(1):69-77.
    View in: PubMed
    Score: 0.190
  15. Effect of Ownership on Hospice Service Use: 2005-2011. J Am Geriatr Soc. 2016 05; 64(5):1024-31.
    View in: PubMed
    Score: 0.170
  16. Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients? Health Serv Res. 2016 Aug; 51(4):1584-94.
    View in: PubMed
    Score: 0.166
  17. How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab. J Oncol Pract. 2015 Jul; 11(4):313-8.
    View in: PubMed
    Score: 0.159
  18. Drug plan design incentives among Medicare prescription drug plans. Am J Manag Care. 2014 Jul; 20(7):562.
    View in: PubMed
    Score: 0.149
  19. Physicians' propensity to discuss prognosis is associated with patients' awareness of prognosis for metastatic cancers. J Palliat Med. 2014 Jun; 17(6):673-82.
    View in: PubMed
    Score: 0.147
  20. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol. 2014 Feb 01; 32(4):306-11.
    View in: PubMed
    Score: 0.144
  21. The impact of emerging safety and effectiveness evidence on the use of physician-administered drugs: the case of bevacizumab for breast cancer. Med Care. 2013 Jul; 51(7):622-7.
    View in: PubMed
    Score: 0.139
  22. Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010. Breast Cancer Res Treat. 2013 Jan; 137(1):285-96.
    View in: PubMed
    Score: 0.133
  23. Physician factors associated with discussions about end-of-life care. Cancer. 2010 Feb 15; 116(4):998-1006.
    View in: PubMed
    Score: 0.110
  24. Financial status, employment, and insurance among older cancer survivors. J Gen Intern Med. 2009 Nov; 24 Suppl 2:S438-45.
    View in: PubMed
    Score: 0.108
  25. Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med. 2009 May 25; 169(10):954-62.
    View in: PubMed
    Score: 0.105
  26. Ownership status and home health care performance. J Aging Soc Policy. 2009 Apr-Jun; 21(2):130-43.
    View in: PubMed
    Score: 0.104
  27. Rejections of drug claims for nursing home residents under Medicare Part D. Health Aff (Millwood). 2008 Mar-Apr; 27(2):560-7.
    View in: PubMed
    Score: 0.096
  28. Using performance data to identify preferred hospitals. Health Serv Res. 2007 Dec; 42(6 Pt 1):2109-19; discussion 2294-323.
    View in: PubMed
    Score: 0.095
  29. Differences in hospice care between home and institutional settings. J Palliat Med. 2007 Oct; 10(5):1040-7.
    View in: PubMed
    Score: 0.094
  30. The influence of Medicare home health payment incentives: does payer source matter? Inquiry. 2006; 43(2):135-49.
    View in: PubMed
    Score: 0.083
  31. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc. 2005 Dec; 53(12):2145-52.
    View in: PubMed
    Score: 0.082
  32. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol. 2012 Dec 10; 30(35):4387-95.
    View in: PubMed
    Score: 0.033
  33. End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012 Feb 07; 156(3):204-10.
    View in: PubMed
    Score: 0.032
  34. Discussions about end-of-life care planning between physicians and patients with stage IV lung or colorectal cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):6026.
    View in: PubMed
    Score: 0.030
  35. Medicare Part D and nursing home residents. J Am Geriatr Soc. 2007 Jul; 55(7):1115-25.
    View in: PubMed
    Score: 0.023
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.